Welcome to the e-CCO Library!

search
Search by: 
Year: Category:
DOP056: Efficacy and safety of anti-fractalkine monoclonal antibody, E6011, in patients with Crohn’s Disease who had lost response to anti-TNF#CHR:alpha_LOWER# agents : A multicentre, open-label, Phase 1/2 study
Year: 2018
Source: ECCO'18 Vienna
Authors: Matsuoka Katsuyoshi
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP056: Pathophysiology of perianal fistulising disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Siegmund B.1, Feakins R.M.2, Barmias G.3, Coelho Ludvig J.4, Vieira Teixeira F.5, Rogler G.6, Scharl M.*7

Created: Wednesday, 20 February 2019, 10:36 AM
DOP056: Pathophysiology of perianal Fistulising Disease
Year: 2017
Source: ECCO'17 Barcelona
Authors: Scharl M.
Perianal disease
Files: 1
DOP056: Pharmacokinetics and exposure-response relationships of golimumab in paediatric patients with moderate-to-severe ulcerative colitis: results from a multicentre open-label study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

O. J. Adedokun*1, D. Chan1, L. Padgett1, Y. Xu1, J. Hyams2, D. Turner3, Z. Xu1, H. Davis1, R. Strauss1

Created: Friday, 22 February 2019, 9:49 AM
DOP056: Pharmacokinetics and Exposure-Response Relationships of Golimumab in Pediatric Patients with Moderate to Severe Ulcerative Colitis: Results from a Multicenter Open Label Study
Year: 2016
Source: ECCO'16 DOP
Authors: Adedokun O.
Ulcerative Colitis, Therapeutic drug monitoring, golimumab
Files: 1
DOP057: ECCO-EBMT joint paper: autologous haematopoietic stem cell transplantation (AHSCT) in severe Crohn’s disease: Summary of the ECCO-EBMT joint review
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Snowden1*, J. Panes2, T. Alexander3, M. Allez4, S. Ardizzone5, D. Dierickx6, J. Finke7, P. Hasselblatt7, C. Hawkey8, M. Kazmi9, J. Lindsay10, F. Onida11, A. Salas2, R. Saccardi12, S. Vermeire13, M. Rovira14, E. Ricart2

Created: Thursday, 21 February 2019, 9:14 AM
DOP057: Perianal pediatric Crohn's disease is associated with a distinct phenotype and greater inflammatory burden
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Assa A.*1, Amitai M.2, Greer M.-L.3, Castro D.3, Cytter Kuint R.4, Martínez-Leόn M.5, Herman-Sucharska I.6, Coppenrath E.7, Anupindi S.8, Towbin A.9, Moote D.10, Konen O.11, Pratt L.-T.12, Grifitths A.3, Turner D.4

Created: Wednesday, 20 February 2019, 10:36 AM
DOP057: Perianal pediatric Crohn's Disease is associated with a distinct phenotype and greater inflammatory burden
Year: 2017
Source: ECCO'17 Barcelona
Authors: Assa A.
Crohn's disease, Disease activity Indices, Perianal fistulae, Perianal disease
Files: 1
DOP057: Tailored step-up approach results in beneficial long-term disease outcome in the prospective Belgian registry of paediatric Crohn’s disease (BELCRO)
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

L. Wauters*1, F. Smets2, E. De Greef3, I. Hoffman4, P. Bontems5, S. Van Biervliet6, I. Paquot7, P. Alliet8, W. Arts9, M. De Vos10, P. Bossuyt11, J.-F. Rahier12, O. Dewit13, T. Moreels13, D. Franchimont14, V. Muls14, F. Fontaine15, E. Louis15, J.-C. Coche16, B. Hauser3, H. Peeters17, E. Van de Vijver18, F. Baert19, S. Vermeire1, G. Veereman3

Created: Friday, 22 February 2019, 9:49 AM
DOP057: Tailored step-up approach results in beneficial long-term disease outcome in the prospective Belgian registry of paediatric Crohn’s disease (BELCRO)
Year: 2016
Source: ECCO'16 DOP
Authors: Wauters L.
anti-TNF agents, Crohn's Disease, thiopurines (AZA/MP)
Files: 1
DOP058: Combined stem cells and anticytokine therapy contributes to a more pronounced decrease in the degree of inflammation of the intestinal mucosa in Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Fadeeva1*, O. Knyazev1, A. Kagramanova1, E. Dobroluybova1, I. Donchenko1, S. Khomeriki2, A. Babayan1, A. Lishchinskaya3, A. Konoplyannikov4

Created: Thursday, 21 February 2019, 9:14 AM
DOP058: Combined stem cells and anticytokine therapy contributes to a more pronounced decrease in the degree of inflammation of the intestinal mucosa in Crohn's Disease
Year: 2018
Source: ECCO'18 Vienna
Authors: Kagramanova Anna
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP058: Does biologic therapy increase the risk for fistula-associated mucinous adenocarcinoma in long standing perianal Crohn's disease?
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Laureti S., Coscia M., Gentilini L., Gionchetti P., Renzi N., Rizzello F., Tanzanu M., Poggioli G.

Created: Wednesday, 20 February 2019, 10:36 AM
DOP058: Does biologic therapy increase the risk for fistula-associated mucinous adenocarcinoma in long standing perianal Crohn’s Disease?
Year: 2017
Source: ECCO'17 Barcelona
Authors: Laureti S.
Perianal fistulae, Perianal disease, Colorectal cancer
Files: 1
DOP058: Long term avoidance of steroids associated with exclusive enteral nutrition as induction therapy in pediatric crohn’s disease does not increase surgery, hospitalizations or biologics use: results of a propensity score-matched cohort analys
Year: 2016
Source: ECCO'16 DOP
Authors: Van Limbergen J.
IBD, Crohn's Disease, paediatrics, nutrition
Files: 1
DOP058: Long-term avoidance of steroids associated with exclusive enteral nutrition as induction therapy in paediatric Crohn’s disease does not increase surgery, hospitalisations or biologics use: results of a propensity score-matched cohort analysis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Basseri1, J. Connors2, A. Grant2, B. MacIntyre2, N. Giffin1, G. Mahdi2, A. Noble2, M. Rashid2, A. R. Otley2, J. Van Limbergen*2

Created: Friday, 22 February 2019, 9:49 AM
DOP059: Combined anticytokine and local mesenchymal stem cells therapy promotes longer healing of simple fistulas in patients with Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Belyakov1*, O. Knyazev1, N. Fadeeva1, N. Orlova2, A. Konoplyannikov3, A. Parfenov1

Created: Thursday, 21 February 2019, 9:14 AM
DOP059: Combined anticytokine and local mesenchymal stem cells therapy promotes longer healing of simple fistulas in patients with Crohn's Disease
Year: 2018
Source: ECCO'18 Vienna
Authors: Kagramanova Anna
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP059: Efficacy of exclusive enteral nutrition in adult active Crohn’s disease with complications or failure of medical treatment
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

Q. Yang, X. Gao*, M. Zhi, H. Chen, N. Ding, S. Hu, J. Guo, P. Hu

Created: Friday, 22 February 2019, 9:49 AM
DOP059: Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn’s Disease with Complications or Failure of Medical Treatment
Year: 2016
Source: ECCO'16 DOP
Authors: Gao X.
exclusive enteral nutrition, abscess
Files: 1